CompletedNCT01908062
Integrated Opioid and Alcohol-Use Treatment in an HIV Clinic
About this title
Read the official source — NCT01908062Medication studyAges 18–100United States + CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 100 years.
- Listed locations
- Chicago and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJune 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 51
- Sponsor
- Oregon Health and Science University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada
- Age range
- From 18 Years to 100 Years
- Official registry ID
- NCT01908062
- Official title
Show the full official title
Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago, United States · Vancouver, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Oregon Health and Science University, a university.
Did this study involve medication?
Yes. The study involved medication, including Extended Release Naltrexone.
Who was this study for?
Listed age limits: 18 years to 100 years.
